Targeting inflammation to fight cancer is a new approach with a long history.

Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.

Combination of two compounds shows promise in the lab

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Read how one caregiver established an association to provide resources for both COPD patients and caregivers.

Discover how COPD assessment and treatment are changing.

Did you know migraine is the most common of all neurological disorders? Learn more surprising facts.

Cynthia lives with Heart Failure with preserved Ejection Fraction, a complex and challenging condition.